Friend or foe—IDH1 mutations in glioma 10 years on

por Huang, L Eric
Publicado 2019

Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma

por Huang, L. Eric
Publicado 2022

From antiangiogenesis to hypoxia: current research and future directions

por Rice, Christopher, Huang, L Eric
Publicado 2010

Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma

por Murnyak, Balazs, Huang, L. Eric
Publicado 2021

Complex role of HIF in cancer: the known, the unknown, and the unexpected

por Tiburcio, Patricia Denise, Choi, Hyunsung, Huang, L Eric
Publicado 2014

The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant glioma

por Tiburcio, Patricia D.B., Locke, Mary C., Bhaskara, Srividya, Chandrasekharan, Mahesh B., Huang, L. Eric
Publicado 2020

Intermittent Induction of HIF-1α Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression

por Choi, Hyunsung, Gillespie, David L., Berg, Shauna, Rice, Christopher, Couldwell, Sandrine, Gu, Jie, Colman, Howard, Jensen, Randy L., Huang, L. Eric
Publicado 2015

IDH1(R132H) is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment

por Tiburcio, Patricia D.B., Xiao, Bing, Chai, Yi, Asper, Sydney, Tripp, Sheryl R., Gillespie, David L., Jensen, Randy L., Huang, L. Eric
Publicado 2018